In conclusion, these results showed that therapeutic T-cell infused to P5 patient, who exhibited a partial response (Table 1) displayed the best profile, both in terms of functional avidity of Melan-A and MELOE-1 specific T cells and of reactivity against target melanoma cells expressing the two antigens. Here, MLANA is linked to melanoma.